Chris Savile

Dr. Chris Savile has been with Willow since April 2019 in the role of Vice President, Commercial Operations. Prior to joining Willow, Dr. Savile worked in senior leadership roles at Intrexon Corporation, a biotechnology company, and Codexis, Inc., a protein engineering company. He is a highly experienced chemist, high throughput assay scientist and protein engineer with a strong technical background. Dr. Savile has been the research and development leader on several programs that led to commercial manufacturing processes. He received his PhD in 2006 from McGill University.